The visitors to Anfield this weekend will be Fulham, who have been in fine form this season and took points off Arsenal in ...

Similarly, the Impella 5.5 with SmartAssist System is approved for short-term use of up to 14 days for paediatric patients ...

Oppenheimer lowered the firm’s price target on Q32 Bio (QTTB) to $20 from $80 and keeps an Outperform rating on the shares.

With a new administration coming in, advocates worry that the FDA may lose its sense of urgency to ban electrical shock ...

Explore the distinctions between active and passive avoidance learning in mice, two fundamental methods used in behavioral ...

Clean systemic toxicity profile and no local side-effects following injection Tiny shock absorbing microparticles support and ...

Kellgren, a clinical psychologist at Tufts Medical Center, about whether Luigi Mangione, the suspect accused of killing former United Healthcare CEO Brian Thompson, showed alarming signs in the months ...

Daily assessment of procalcitonin (PCT), rather than standard care alone, led to patients spending significantly less time on ...

The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...